US Stock MarketDetailed Quotes

ENDRA Life Sciences (NDRA)

Watchlist
  • 6.400
  • +1.230+23.79%
Close Apr 17 16:00 ET
  • 6.060
  • -0.340-5.31%
Post 20:01 ET
7.94MMarket Cap-0.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ENDRA Life Sciences (NDRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-46.72%5.76M
-62.25%1.62M
-9.17%1.37M
-41.68%1.3M
-47.16%1.47M
2.82%10.82M
194.75%4.3M
-51.77%1.51M
-25.50%2.23M
-5.40%2.78M
Selling and administrative expenses
-48.69%3.91M
-69.56%1.11M
31.35%938.59K
-39.25%920.03K
-45.91%940.6K
38.24%7.63M
316.51%3.66M
-52.24%714.57K
-5.01%1.51M
12.34%1.74M
-Selling and marketing expense
-66.82%189.47K
-92.63%6.36K
-45.54%45.29K
-57.76%68.83K
-71.09%68.99K
-30.41%571.04K
-41.64%86.27K
-65.83%83.16K
-34.23%162.95K
31.41%238.66K
-General and administrative expense
-47.23%3.72M
-69.00%1.11M
41.48%893.31K
-37.02%851.2K
-41.91%871.61K
50.24%7.06M
388.99%3.57M
-49.60%631.41K
0.37%1.35M
9.80%1.5M
Research and development costs
-42.01%1.85M
-20.35%508.14K
-45.61%432.11K
-46.81%381.06K
-49.24%528.69K
-36.24%3.19M
10.12%637.96K
-51.35%794.44K
-48.84%716.37K
-25.14%1.04M
Operating profit
46.72%-5.76M
62.25%-1.62M
9.17%-1.37M
41.68%-1.3M
47.16%-1.47M
-2.82%-10.82M
-194.75%-4.3M
51.77%-1.51M
25.50%-2.23M
5.40%-2.78M
Net non-operating interest income expense
-7.32M
0
-7.32M
0
Total other finance cost
----
----
----
----
----
--7.32M
--0
--7.32M
----
----
Other net income (expense)
-83.02%-1.26M
-1,147.27%-1.55M
73.34%-225.26K
4,322.24%75.18K
8,843.44%432.95K
-250.02%-690.8K
8,513.15%147.74K
-3,093.96%-845.08K
-99.61%1.7K
241.63%4.84K
Gain on sale of security
-67.73%-1.34M
-1,487.04%-1.54M
70.65%-267.27K
--62.11K
--408.56K
---799.28K
--111.32K
---910.6K
----
----
Other non- operating income (expenses)
-29.63%76.35K
-108.59%-3.13K
-35.88%42.02K
668.59%13.07K
403.82%24.39K
-76.44%108.48K
2,173.75%36.42K
132.15%65.53K
-99.61%1.7K
241.63%4.84K
Income before tax
38.93%-7.03M
23.62%-3.17M
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
38.93%-7.03M
23.62%-3.17M
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
Net income continuous Operations
38.93%-7.03M
23.62%-3.17M
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
Minority interest income
Net income attributable to the parent company
38.93%-7.03M
23.62%-3.17M
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
38.93%-7.03M
23.62%-3.17M
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
Basic earnings per share
84.32%-8.93
57.94%-3.25
77.99%-2.1
-2,037.50%-1.71
99.59%-1.86
97.94%-56.94
97.02%-7.7276
98.56%-9.54
99.99%-0.08
72.38%-449.58
Diluted earnings per share
84.32%-8.93
57.94%-3.25
77.99%-2.1
-2,037.50%-1.71
99.59%-1.86
97.94%-56.94
97.02%-7.7276
98.56%-9.54
99.99%-0.08
72.38%-449.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -46.72%5.76M-62.25%1.62M-9.17%1.37M-41.68%1.3M-47.16%1.47M2.82%10.82M194.75%4.3M-51.77%1.51M-25.50%2.23M-5.40%2.78M
Selling and administrative expenses -48.69%3.91M-69.56%1.11M31.35%938.59K-39.25%920.03K-45.91%940.6K38.24%7.63M316.51%3.66M-52.24%714.57K-5.01%1.51M12.34%1.74M
-Selling and marketing expense -66.82%189.47K-92.63%6.36K-45.54%45.29K-57.76%68.83K-71.09%68.99K-30.41%571.04K-41.64%86.27K-65.83%83.16K-34.23%162.95K31.41%238.66K
-General and administrative expense -47.23%3.72M-69.00%1.11M41.48%893.31K-37.02%851.2K-41.91%871.61K50.24%7.06M388.99%3.57M-49.60%631.41K0.37%1.35M9.80%1.5M
Research and development costs -42.01%1.85M-20.35%508.14K-45.61%432.11K-46.81%381.06K-49.24%528.69K-36.24%3.19M10.12%637.96K-51.35%794.44K-48.84%716.37K-25.14%1.04M
Operating profit 46.72%-5.76M62.25%-1.62M9.17%-1.37M41.68%-1.3M47.16%-1.47M-2.82%-10.82M-194.75%-4.3M51.77%-1.51M25.50%-2.23M5.40%-2.78M
Net non-operating interest income expense -7.32M0-7.32M0
Total other finance cost ----------------------7.32M--0--7.32M--------
Other net income (expense) -83.02%-1.26M-1,147.27%-1.55M73.34%-225.26K4,322.24%75.18K8,843.44%432.95K-250.02%-690.8K8,513.15%147.74K-3,093.96%-845.08K-99.61%1.7K241.63%4.84K
Gain on sale of security -67.73%-1.34M-1,487.04%-1.54M70.65%-267.27K--62.11K--408.56K---799.28K--111.32K---910.6K--------
Other non- operating income (expenses) -29.63%76.35K-108.59%-3.13K-35.88%42.02K668.59%13.07K403.82%24.39K-76.44%108.48K2,173.75%36.42K132.15%65.53K-99.61%1.7K241.63%4.84K
Income before tax 38.93%-7.03M23.62%-3.17M32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M
Income tax 0000000000
Net income 38.93%-7.03M23.62%-3.17M32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M
Net income continuous Operations 38.93%-7.03M23.62%-3.17M32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M
Minority interest income
Net income attributable to the parent company 38.93%-7.03M23.62%-3.17M32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 38.93%-7.03M23.62%-3.17M32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M
Basic earnings per share 84.32%-8.9357.94%-3.2577.99%-2.1-2,037.50%-1.7199.59%-1.8697.94%-56.9497.02%-7.727698.56%-9.5499.99%-0.0872.38%-449.58
Diluted earnings per share 84.32%-8.9357.94%-3.2577.99%-2.1-2,037.50%-1.7199.59%-1.8697.94%-56.9497.02%-7.727698.56%-9.5499.99%-0.0872.38%-449.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -